AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.2540
-0.0044 (-1.70%)
At close: Aug 24, 2026, 4:00 PM EDT
0.2562
+0.0022 (0.87%)
After-hours: Aug 24, 2026, 7:30 PM EDT
AIM ImmunoTech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9.9 | 2.99 | 1.7 | 5.44 | 27.05 | 32.09 |
Short-Term Investments | 0.06 | 0.06 | 2.28 | 7.63 | 7.14 | 16.18 |
Cash & Short-Term Investments | 9.96 | 3.05 | 3.98 | 13.07 | 34.19 | 48.27 |
Cash Growth | 1093.29% | -23.38% | -69.57% | -61.77% | -29.17% | 23.76% |
Other Receivables | - | 0.01 | - | 1.18 | 1.68 | 1.64 |
Receivables | - | 0.01 | - | 1.18 | 1.68 | 1.64 |
Prepaid Expenses | 0.47 | 0.24 | 0.2 | 0.3 | 0.46 | 0.3 |
Total Current Assets | 10.43 | 3.3 | 4.18 | 14.56 | 36.32 | 50.21 |
Property, Plant & Equipment | 0.31 | 0.45 | 0.73 | 0.82 | 1.02 | 4.2 |
Other Intangible Assets | 1.71 | 1.66 | 2.59 | 2.31 | 1.94 | 1.97 |
Long-Term Deferred Tax Assets | - | - | - | 1.6 | 1.12 | - |
Other Long-Term Assets | 0.27 | 0.38 | 1.11 | 0.08 | 0.08 | 1.32 |
Total Assets | 12.73 | 5.78 | 8.61 | 19.38 | 40.49 | 57.7 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.48 | 1.63 | 6.38 | 6.44 | 0.38 | 0.2 |
Accrued Expenses | 0.59 | 0.8 | 0.61 | 1.99 | 0.81 | 0.44 |
Current Portion of Long-Term Debt | 3.62 | 3.55 | 2.31 | - | - | - |
Current Portion of Leases | 0.26 | 0.25 | 0.24 | 0.22 | 0.18 | 0.04 |
Total Current Liabilities | 4.95 | 6.22 | 9.54 | 8.65 | 1.36 | 0.67 |
Long-Term Debt | - | 0.93 | - | - | - | - |
Long-Term Leases | 0.04 | 0.17 | 0.4 | 0.5 | 0.66 | 0.11 |
Other Long-Term Liabilities | - | 8.24 | - | - | - | 0.04 |
Total Liabilities | 4.99 | 15.57 | 9.93 | 9.15 | 2.02 | 0.82 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.03 | 0 | 0 | 0.05 | 0.05 | 0.05 |
Additional Paid-In Capital | 455.31 | 431 | 425.51 | 419 | 418.27 | 417.22 |
Retained Earnings | -447.6 | -440.79 | -426.83 | -409.51 | -380.55 | -361.1 |
Total Common Equity | 7.74 | -9.78 | -1.32 | 9.55 | 37.77 | 56.16 |
Shareholders' Equity | 7.74 | -9.78 | -1.32 | 10.23 | 38.47 | 56.88 |
Total Liabilities & Equity | 12.73 | 5.78 | 8.61 | 19.38 | 40.49 | 57.7 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 3.92 | 4.9 | 2.94 | 0.72 | 0.84 | 0.15 |
Net Cash (Debt) | 6.04 | -1.85 | 1.04 | 12.35 | 33.35 | 48.12 |
Net Cash Growth | - | - | -91.61% | -62.97% | -30.69% | -7.63% |
Net Cash Per Share | 0.91 | -1.14 | 1.85 | 25.40 | 69.35 | 101.54 |
Filing Date Shares Outstanding | 30.44 | 8.15 | 0.72 | 0.5 | 0.48 | 0.48 |
Total Common Shares Outstanding | 28.99 | 3.07 | 0.66 | 0.49 | 0.48 | 0.48 |
Working Capital | 5.49 | -2.93 | -5.36 | 5.9 | 34.96 | 49.54 |
Book Value Per Share | 0.27 | -3.19 | -2.02 | 19.42 | 78.48 | 116.90 |
Tangible Book Value | 6.03 | -11.44 | -3.92 | 7.23 | 35.83 | 54.19 |
Tangible Book Value Per Share | 0.21 | -3.73 | -5.97 | 14.71 | 74.44 | 112.80 |
Land | - | - | - | - | - | 3.9 |
Machinery | 1.47 | 1.47 | 1.47 | 1.45 | 2.23 | 2.35 |